Patients and methods
angiography. Complete angiographical follow-up was performed after 77% of the angioplasties. The angiography was Table 1 shows the demographic data of the patients. We done after 120±82 days, range 1 month to 2 years. Final examined the data of 135 consecutive patients undergoing follow-up angiography was performed after 273±345 days, PTRA between 1982 and 1993, treated bilaterally (n=67), range 1 month to 6.3 years. unilaterally for one functioning kidney (n=53), unilaterally leaving the contralateral stenosis/occlusion untreated (n= Clinical evaluation, analysis and follow-up 12) and unilaterally when the contralateral kidney was small (n=3). Patients treated after 1993 were included when the The duration of hypertension, co-morbidity, serum creatinfirst PTRA was performed before 1993. Seventy five percent ine, blood pressure and antihypertensive drugs were recorded of the patients had atherosclerotic disease in addition to the before the PTRA and at follow-up. Clinical data before the renal artery disease, such as abdominal aortic aneurysm, and PTRA were obtained in all patients. Twenty one patients did coronary, cerebrovascular and peripheral artery disease.
not have complete follow-up data for creatinine and blood Renal parenchymal disease was diagnosed in 26 (19%), 24 pressure because of death (n=9), uraemia (n=6) and data men and two women. These included chronic glomerulomissing (n=6), giving a follow-up of 85%. The presented nephritis (n=9), nephrosclerosis (n=10), chronic pyelodata are from before the first PTRA and after the last PTRA, nephritis/renal calculus (n=6) and adult polycystic kidney mean follow-up after 414±558 days, range 40 days to 8.7 disease (n=1).
years. The patient survival data were obtained from the Norwegian National Registry, giving 100% follow-up. Renal
The angioplasty procedure, analysis and follow-up replacement therapy data was obtained from the Norwegian Renal Replacement Registry, giving information about all The coaxial technique (guiding catheter-assisted angioplasty) the patients. The mean follow-up period from the initial was used in nearly all patients (91%) [14] [15] [16] . A stent was PTRA regarding renal replacement therapy and survival was placed in 17 patients. The mean number of procedures 8.8 years, range 5.5-14.8 years. was 1.7 per patient, and 1.7 stenoses were treated per patient.
The effects on renal function were evaluated by measuring Acetylsalicylic acid 500 mg was given the day before interven-the serum creatinine. Improved renal function was defined tion. A calcium antagonist was given in the radiology suite, as a decrease in creatinine of Á20% when baseline was unless the patient was already being treated with such >100 mmol/l, and a decrease of Á20 mmol/l when baseline medication. After placement of the guiding catheter, an was ∏100 mmol/l. Deteriorated renal function was defined intravenous bolus of 5.000 U of heparin was given. When as an increase in creatinine of Á20% when baseline was the stent was implanted, warfarin p.o. and heparin infusion >100 mmol/l, and an increase of Á20 mmol/l when baseline (10 U/kg/h) were given after the procedure.
was ∏100 mmol/l. The other patients were defined as having All films of the PTRAs had been stored separately in our a stabilized renal function. hospital for this study. The angiograms were evaluated by The effects of PTRA on blood pressure were evaluradiologists unaware of the therapeutic result. All angio-ated using diastolic blood pressure and the defined daily graphies were reviewed retrospectively using a caliper. The doses (DDD) of antihypertensive drugs ( World Health degree of the stenosis was calculated from one single projec-Organization Collaborating Center for Drug Statistics tion in terms of diameter reduction as a percentage. Lesions Methodology, January 1994). Blood pressure was measured within 5 mm from the aortic lumen were defined as ostial in mmHg, using a mercury sphygmomanometer with the stenoses. Significant stenosis was defined as a diameter patient seated. Arterial hypertension was considered to be reduction of Á50% or pressure gradient Á20 mmHg. A cured when blood pressure was ∏140/90 mmHg without successful outcome included no significant residual stenosis antihypertensive medication, as improved when the diastolic in any of the treated renal arteries, an unsuccessful outcome blood pressure was reduced by Á10 mmHg and the DDD was defined as no arteries successfully treated or improved, was unchanged or decreased, and as a deterioration when and improvement was classified as those in between. The the diastolic blood pressure increased by Á10 mmHg and analysis of each stenosis was performed using significant/ the DDD was unchanged or increased. The other patients non-significant as outcome criteria. The immediate outcome, were defined to have unchanged blood pressure. and the primary and secondary patency were evaluated for each patient. Failed procedures were included in the patency
Statistical methods

calculations.
Mean±1 SD were used to express the data. Statistical computations were carried out using Biomedical Datapack PTRA: two were complications, with acute occlusion and successful surgery in one and an interrupted procedure because of acute heart failure in the other. Four failures were failed attempts to open the artery: two had successful surgery, one was treated successfully at a second attempt and the fourth was left with bilateral ostial lesions. The primary patency rate was 43%, and the secondary patency rate was 64%.
Evaluating each stenosis, the immediate success was 93%, the primary patency rate 55% and the secondary patency rate 72%. There was a significantly lower secondary patency rate for angioplasty of vessels <5 mm (43%, P=0.001). There was a tendency for a lower secondary patency rate in patients with abdominal aortic aneurysm (67%) than when the aorta was angiographically normal (86%). There was no significant difference between ostial lesions (71%) and lesions in the main renal artery (77%).
Twenty stents were placed at 18 procedures into 17 patients: at the initial procedure (n=5), at the second procedure (n=6), at the third (n=2), at the fourth (n=1), at the fifth (n=3) and at the sixth (n=1). The immediate technical result showed that the diameter of the stenosis was reduced from 75% (50-95%) to 10% (0-33%). At follow-up in 11 patients, the stenosis was 17%, range 0-50%. One of these had significant restenosis, she was re-angioplastied successfully, but the stent stenosis recurred and further treatment was abandoned. Another three patients were treated with surgical revascularization, of the same side in two (10 and 12 months) and the contralateral side in one.
Effects on blood pressure
The effects on blood pressure were correlated with baseline serum creatinine ( Table 2 ). The systolic and diastolic blood pressures decreased significantly and the DDD was reduced when creatinine was ∏250 mmol/l. When creatinine was >250 mmol/l, there were no overall effects on the blood pressure or on the number of antihypertensive drugs. All patients with systolic blood pressure >210 mmHg (n=15) and all patients with diastolic blood pressure >115 mmHg (n=13) improved. When the systolic blood pressure was >210 mmHg, the systolic blood pressure decreased from 232±22 to 162±27 mmHg and the diastolic blood pressure decreased from 114±16 to 90±11 mmHg. In patients with either recent onset of hypertension (<12 months) or recent aggravation of hypertension (n=21), the blood pressure decreased from 181±24/106±12 to 159±29/92±14 (P<0.001) and the DDD decreased from 2.9±1.3 to 2.0±1.8 (P<0.01).
Seven patients (6%) were cured, 44 (36%) were improved, 56 (41%) were unchanged and eight (6%) had higher blood pressure at control. Patients with a successful blood pressure outcome were younger (61.2 years vs. 65.2 years, P=0.05) and had a higher diastolic blood pressure (105 mmHg vs. 93.7 mmHg, P<0.0001). 
Effects on renal function
increased serum creatinine >50% (n=5), serious complication in one, and lung cancer in one. The mean Table 2 shows the effects on serum creatinine related baseline serum creatinine was higher in this group than to the baseline serum creatinine. There were no signi-in the other patients, 380 mmol/l vs 172 mmol/l ficant effects on creatinine in any of the groups. (P<0.001). More of these patients had cardiovascular However, patients with either recent onset of hyperten-disease, 81% vs 23% (P<0.001), more had cerebrovassion (<12 months) or recent aggravation of hyperten-cular disease, 41% vs 18% (P=0.08), and more had sion (n=21) had a significant reduction, from 155 to renal parenchymal disease, 47% vs 11% (P<0.001). 125 mmol/l (P<0.006). Excluding 15 patients with an Mean age, gender, blood pressure, and number of increase in creatinine of >50%, the creatinine patients with aortic aneurysm, diabetes and claudicadecreased from 175±86 to 159±79 mmol/l (P=0.005). tion were not statistically significantly different between Table 3 summarizes the results of renal outcome related the two groups. to baseline serum creatinine. In total, 23% were improved, 56% were stabilized and 21% were worse.
Long-term renal survival When creatinine was <125 mmol/l, 85% of the patients were improved or stabilized. Over the following 6 Figure 1 shows the percentage of patients that did not months, one patient died, two underwent renovascular have dialysis, renal artery surgery or kidney transsurgery and no patients underwent dialysis. When plantation after renal angioplasty, related to the basecreatinine was between 125 and 250 mmol/l, 85% were line serum creatinine. Two patients having dialysis at improved or stabilized and 15% were worse. One of the time of PTRA were excluded. In total, 16 patients the patients with stabilized function had a serious non-started haemodialysis after the PTRA, two were allorenal complication, spinal anterior syndrome. Over the transplanted, and 14 were treated with surgical revascufollowing 6 months, four died, two underwent reno-larization (three with aorto-renal bypass and 11 with vascular surgery and one underwent dialysis but later auto-transplantation). Two of these underwent successdied. When creatinine was >250 mmol/l, 60% were ful emergency surgery after angioplasty failure. None improved or stabilized and 39% were worse. Two of of the patients with baseline serum creatinine these patients died from complications before the <125 mmol/l underwent dialysis during follow-up, but follow-up creatinine was measured. Ten patients died and five underwent dialysis within 6 months. One of the patients underwent dialysis but died later.
There were significantly more patients with improved or stabilized function when creatinine was ∏250 mmol/l than when it was >250 mmol/l (P<0.01). Of these 26 patients with renal parenchymal disease none had improved renal function; 13 (50%) were stabilized and 13 (50%) had deteriorated. Patients with known atherosclerotic disease of more than two organs (n=57) had a higher risk of deterioration of renal function than those with less extensive disease (n=78), 34% vs 19% (NS). For patients with aortic aneurysm, the numbers were 40% vs 23% (NS). There was no difference in renal outcome between patients with one functional kidney and those with bilateral stenosis, and there was no difference between the age of those with improved or stabilized renal function and those poor outcome from the PTRA: because of death Two patients undergoing dialysis at the time of PTRA were excluded (including two complications) at <6 months (n=16), from the analysis. The numbers above the curves show the numbers at risk.
renal replacement therapy at <6 months (n=9), eight (21%) patients were treated by surgery. Three (5%) patients with creatinine 125-250 mmol/l underwent dialysis 41 days, 7.4 and 8 years after PTRA, one was allo-transplanted after 4 years 6 months, and five (8%) underwent surgical revascularization. Thirteen (38%) of the patients with creatinine >250 mmol/l underwent dialysis after a mean of 1.4 years, range 7 days-8 years, one was allo-transplanted after 7 months, and none underwent surgical revascularization.
Complications
Twelve patients (9%) experienced one or more complications, giving a complication rate per procedure of 5%. The complications included two deaths. One patient developed renal failure resulting in cardiac Fig. 2 . Kaplan-Meier curves showing survival as a percentage after death after 18 days from pericardial effusion. The other renal angioplasty related to the baseline serum creatinine. The patient died from a myocardial infarction after 33 days numbers above the curves show the numbers at risk. during surgical repair of a pseudoaneurysm at the puncture site. One patient developed paraplegia (th respectively. When creatinine was >250 mmol/l, the 5-12) with permanent damage. Two main renal artery year survival rate was significantly lower than that of occlusions were both auto-transplanted successfully, the two other groups (P<0.001). For all the patients, one at the first PTRA and one at the fourth. Other the 5-year survival rate was lower when coronary heart complications were retroperitoneal haematoma in one disease, 43% vs. 75% (P<0.001), cerebrovascular dis-(no operation), pulmonary oedema in one, pseudoanease, 44% vs. 62% (NS) or aortic abdominal aneurysm, eurysm in three, stent removed surgically at the punc-33% vs. 61% (P=0.08) were present. The 5-year surture site in one, and segmental renal infarction in one.
vival rate was 31% when renal parenchymal disease, One of the patients who underwent emergency auto-50% claudication and 50% diabetes mellitus were pretransplantation was transfused for puncture site haemsent. In patients with both creatinine >250 mmol/l and atoma at a previous angioplasty. Another patient was coronary heart disease (n=29), the 5-year survival rate operated on for an arterio-veneous fistula at the puncwas 7% (two out of 29 patients). ture site after follow-up angiography between the third and the fourth angioplasty, the only known complication from the pre-and post-procedural angiographies.
Discussion
Ten patients (7%) had deterioration of the renal function that possibly could be related to the procedure. Five patients started renal replacement therapy The overall results of PTRA of 419 consecutive patients at our hospital from 1982 to 1993 recently have been within 1 year following a serum creatinine increase after the PTRA, and another five patients experienced published, comprising 595 PTRA procedures [14] . This study presents the results of renal artery angioplasty a >50% increase of serum creatinine within 3 months. One of these patients underwent an emergency opera-of a subgroup of patients with high risk of renal artery occlusion and development of end-stage renal failure. tion with auto-transplantation because of renal artery occlusion. The renal function of the other nine patients A large series of atherosclerotic patients having undergone PTRA to prevent the need for renal replacement deteriorated after technically successful procedures. therapy has not been published to date. Consequently, this indication for PTRA so far has not been well Patient survival supported by evidence-based data. The number of patients starting dialysis due to ESRD from ischaemic Eighty (59%) of the patients died during follow-up. The mean observation time from first PTRA to death nephropathy has increased over the last few years. It has been estimated that ischaemic nephropathy is the was 2.8 years (range 6 days-13.1 years) and the mean age at death was 70.3 years (range 41.4-82.6 years). cause of renal replacement therapy in 21% of patients aged over 65 years [17] . A recent study has shown an For all patients, the actuarial 1-and 5-year patient survival rates were 82 and 58%, respectively. Two 11% risk of occlusion after 2 years when the renal artery stenoses were Á60% [7] . Other studies are in patients died within 30 days, another five between 30 and 60 days, and one between 60 and 90 days. All agreement with this report [4, [6] [7] [8] . PTRA may be performed prophylactically to prevent reduced renal these eight patients suffered from advanced atherosclerotic disease.
function or prevent further deterioration of renal function, i.e. in patients with bilateral stenoses, or unilateral Figure 2 shows the survival related to baseline serum creatinine; zero is the time of the first PTRA. The stenosis in patients with one functioning kidney. No prospective randomized study has been performed to 5-year survival rates were 84, 66 and 17% for creatinine <125 mmol/l, 125-250 mmol/l, and >250 mmol/l, compare revascularization of renal artery stenoses and observation without intervention. Such a study is prob-aggravation of hypertension. That fewer patients with baseline serum creatinine >250 mmol/l improved or ably impossible to conduct. However, one retrospective study has indicated that mortality was higher in stabilized their renal function may be explained by irreversible nephron loss. When treating this group of patients who were left untreated than in patients in whom revascularization had been performed [18] .
patients, one has to take into consideration that in some patients renal function may even deteriorate after the procedure. The same consideration applies to Angiographical results patients with extensive atherosclerotic disease or renal parenchymal disease. The immediate angiographical result after angioplasty of atherosclerotic renal artery stenoses, i.e. 90% sucDuring follow-up none of the 38 patients with normal serum creatinine and only three of 61 with cessful treatment and 5% improvement, is quite satisfactory. In a recent review [13] of 19 studies with 1032 creatinine 125-250 mmol/l required haemodialysis. The question is whether PTRA prevented deterioration of patients, range 8-165 patients, with atherosclerotic disease, technical success was 80%, range 46-100%. renal function. Data on the natural course of renal artery stenosis are scarce. One prospective study found Our results showed low primary and secondary patency rates, 43 and 64%, respectively. The patency rates for an 11% risk of occlusion over 2 years when renal artery stenosis Á60% was present, as evaluated by duplex the individual stenoses were higher, but low numbers were seen overall, since many patients had angioplasty ultrasonography [7] . Extrapolating this information to our patients, one would have expected renal failure in of more than one artery. Therefore, the number of patients that obtained some benefit from the angiopla-many of them. The small number of patients requiring dialysis or transplantation, at least when creatinine sty was probably higher than the patency rates may indicate.
was normal or moderately elevated at the time of the procedure, is compatible with the notion that longThe main disadvantage of angioplasty of renal artery stenoses is the high restenosis rate. We have shown term preservation of renal function has been achieved.
Obviously, we preserved renal function even in a that re-angioplasty will result in an improved secondary patency rate. It is possible that restenosis can be certain proportion of patients with creatinine >250 mmol/l, but overall in this group, survival was reduced with placement of stents [19] [20] [21] , but data so far are not consistent [13] . Surgical repair is known to low, complications were frequent, and a large number of patients ultimately required dialysis. The two be effective and should always be considered [12, [22] [23] [24] . Although the complication rate is higher patients on haemodialysis before PTRA did not regain renal function. This observation supports the view that and the complications are more serious than with angioplasty, these risks have to be weighed against the such patients are difficult to treat successfully with PTRA, despite some positive case reports [37, 38] . need to undergo multiple angioplasty procedures.
From our data and from past publications, followup examination to detect recurrent stenosis is mandat-Complications ory. Whether the follow-up should be intra-arterial angiography or a non-invasive test is moot. We have The number of complications was higher than usually seen with angioplasty, but is comparable with that performed intra-arterial angiography for follow-up, but it is possible that non-invasive tests such as Doppler found in recent reports on PTRA in atherosclerotic patients [33, 39, 40] . The risk is particularly high in sonography [25] [26] [27] , magnetic resonance angiography [28] [29] [30] or volumetric spiral computerized tomography patients with advanced atherosclerosis and uraemia [41] . Although the two deaths which did occur did not [31, 32] can replace the angiography in this situation. Although these methods are inferior to the intra-happen immediately after the angioplasty, they were both clearly related to the procedure. Both patients arterial angiography to the detection of renal artery stenoses, they are reliable for the detection of proximal had extensive atherosclerotic disease and severely reduced renal function. The patient that experienced stenoses and can, therefore, be used in most patients.
paresis had severe changes of the abdominal aorta. When stents were first used, anticoagulation was more Renal function extensive in this initial period than at the present time. Some of the puncture site and bleeding complication Patients with long-standing hypertension and impaired renal function due to chronic ischaemic disease may were undoubtedly related to the more intensive anticoagulation regime. We are now giving the patients already have irreversible nephron loss so that improvement after angioplasty cannot be expected. Few studies antiplatelet drugs after stent placement.
Many patients experienced deterioration of renal have actually shown improved renal function after revascularization. At best, angioplasty can prevent function after a technically successful procedure. It is difficult to decide if this was related to the procedure further deterioration. Stabilization or improvement of renal function in 76% is a favourable result compared per se, or reflected progression as part of the natural history of this condition. It is also known that choleswith those of previous studies in small cohorts [21, [33] [34] [35] [36] . We found that patients who did better terol emboli released during the balloon dilatation may reduce renal function. Furthermore, one has also to were characterized by normal or slightly impaired renal function, and by recent onset or recent (<12 months) consider that the contrast medium used may induce 14. Kløw NE, Paulsen D, Vatne K et al. Percutaneous transluminal renal failure, particularly in patients with reduced renal renal artery angioplasty using the coaxial technique-ten years function and diabetes. The risk is related to the volume of experience from 591 procedures in 419 patients. Acta Radiol that is given [42, 43] . There may be a role for CO 2 1998; 39: 594-603 contrast angiography in the future. 
